Global Travelers Vaccines Sales Market Size By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine), By Application (Tourists, Students), By Region, And Segment Forecasts, 2023 to 2032

The Global Travelers Vaccines Sales Market was valued at USD 10.5 billion in 2023 and is expected to reach USD 18.2 billion by the end of 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. The increasing number of international travelers, rising awareness about vaccine-preventable diseases, and the growing importance of immunization programs by health organizations are key factors propelling market growth.

Travelers' vaccines are designed to protect against infectious diseases that may not be prevalent in a traveler's home country but pose risks in the destination region. With the resurgence of global tourism post-pandemic, the demand for vaccines against diseases such as yellow fever, typhoid, hepatitis A, and meningococcal infections is on the rise.

Market Drivers:

Increasing Global Travel and Tourism:

The significant growth in international travel, driven by business, leisure, and medical tourism, is fueling demand for travelers' vaccines. Many countries now mandate certain vaccinations as entry requirements, boosting vaccine sales.

Rise in Awareness of Travel-Related Diseases:

With increased global connectivity, travelers are more exposed to health risks. Governments and healthcare agencies are promoting vaccine awareness campaigns, encouraging travelers to get vaccinated before visiting high-risk regions.

Expansion of Immunization Programs:

Organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have intensified efforts to ensure widespread vaccination coverage, especially in areas with high disease prevalence.

Market Restraints:

High Cost of Vaccinations:

Many travelers’ vaccines, such as those for Japanese encephalitis and rabies, are expensive, discouraging travelers from getting vaccinated, especially in low-income countries where insurance coverage is limited.

Limited Awareness in Emerging Markets:

In some developing regions, awareness about travel-related vaccines remains low, leading to reduced adoption rates.

Market Opportunities:

Growth in Emerging Economies:

As middle-class populations expand in Asia-Pacific, Latin America, and Africa, there is an increase in international travel, creating new market opportunities for vaccine manufacturers.

Technological Advancements in Vaccine Development:

The introduction of single-dose vaccines, needle-free delivery systems, and enhanced cold-chain storage solutions is improving vaccine accessibility and efficiency, further driving market expansion.

Government and Private Sector Initiatives:

Public-private partnerships are emerging as a key strategy to increase vaccination rates among travelers, particularly through collaborations between airlines, travel agencies, and healthcare providers.

Market by Vaccine Type Insights:

By Vaccine Type:

Live Attenuated Vaccines: These include yellow fever and oral typhoid vaccines and held the largest market share in 2023 due to their long-lasting immunity.

Inactivated Vaccines: Hepatitis A and cholera vaccines fall under this category, gaining traction due to improved storage stability.

Conjugate & Subunit Vaccines: Meningococcal and pneumococcal vaccines are witnessing increased demand due to growing regulatory recommendations.

Market by End-Use Insights:

By End-Use:

Hospitals & Travel Clinics: Accounted for over 50% of sales in 2023, as travelers often seek vaccinations from hospitals and specialized travel health clinics.

Retail Pharmacies: Increasing access to vaccines at retail pharmacies is expected to drive growth in this segment.

Online Pharmacies & Direct Sales: Growing popularity of online bookings for vaccinations is contributing to market expansion.

Market by Regional Insights:

North America led the market in 2023, driven by high vaccine awareness, strong regulatory frameworks, and well-established healthcare infrastructure.

Europe follows closely due to strict travel health policies and increasing outbound tourism.

Asia-Pacific is anticipated to witness the fastest growth, supported by rising disposable incomes and increasing awareness about travel-related diseases.

Latin America & Middle East & Africa are emerging markets with growing opportunities due to expanding tourism and government initiatives.

Competitive Scenario:

Key Market Players:

Sanofi Pasteur

GlaxoSmithKline (GSK)

Pfizer Inc.

Merck & Co., Inc.

Novartis AG

Emergent BioSolutions

Takeda Pharmaceutical Company

Bavarian Nordic

Valneva SE

Biomérieux

These companies are focusing on new product launches, partnerships, and technological innovations to strengthen their market presence.

Key Market Developments:

In 2023, Sanofi Pasteur launched a new, long-acting hepatitis A vaccine with enhanced storage capabilities.

GSK introduced an improved meningococcal vaccine targeting high-risk travel destinations.

Pfizer announced a strategic partnership with airlines to promote vaccine awareness among international travelers.

Scope of Work – Global Travelers Vaccines Sales Market